Table 5.
FA biomarker candidates in studies included in the systematic review of IBD
| Author (year) | IBD type | Sample | FA biomarker candidate | Additional description |
|---|---|---|---|---|
| Manfredi et al. (2019) | CD/UC | Serum | Eicosapentaenoic acid | |
| Docosahexaenoic acid | ||||
| Linoleic acid | ||||
| Tridecylic acid | ||||
| Caprylic acid | ||||
| Behenic acid | ||||
| Lignoceric acid | ||||
| Arachidic acid | ||||
| Tricosylic acid | ||||
| Arachidonic acid | ||||
| Icosadienoic acid | ||||
| Nervonic acid | ||||
| Paulinic acid | ||||
| Suberic acid | ||||
| Horta et al. (2021) | Fatigue CD | Plasma | Leukotriene B4 | FA biomarker candidates in the 50 most discriminant biomarkers. |
| 15S-HpETE | ||||
| 16R-HETE | ||||
| Guan et al. (2020) | CD/UC | Plasma | 12,13S-EOT | FA biomarker candidates in the 55 most discriminant biomarkers. |
| Arachidonic acid | ||||
| Eicosapentaenoic acid | ||||
| 5,6-EpETrE | ||||
| 2-hydroxyglutaric acid | ||||
| Docosahexaenoic acid | ||||
| 8,9-EpETrE | ||||
| 8R-HpODE | ||||
| Nervonic acid | ||||
| 9,12,13-TriHOME | ||||
| Palmitic acid | ||||
| 2E-decenoyl-CoA | ||||
| 9-heptadecylenic acid | ||||
| Traumatic acid | ||||
| 20-HETE | ||||
| Cis-9-palmitoleic acid | ||||
| Bazarganipour et al. (2019) | UC | Plasma | FA 16:0, FA 18:0, FA 18:1, FA 20:1, FA 20:4, FA 20:5, FA 22:3, FA 22:4, FA 22:5 | Although lipidomic analysis was done by using both plasma and tissue samples, fatty acid subclass was revealed only in plasma samples. |
| Eicosapentaenoic acid | ||||
| Docosahexaenoic acid | ||||
| Jansson et al. (2009) | CD | Feces | Oleic acid | |
| Stearic acid | ||||
| Palmitic acid | ||||
| Arachidonic acid | ||||
| Octadecatrienoic acid | ||||
| Linoleic acid | ||||
| Prostaglandin F2α | ||||
| 2,3-dinor-8-iso-prostaglandin F2α | ||||
| Prostaglandin F1α | ||||
| Prostaglandin E2α | ||||
| Murgia et al. (2018) | CD | Plasma | FA 16:0, FA 16:1, FA 18:0, FA 18:1, FA 18:2, FA 22:1, FA 24:2, FA 24:3 | |
| Bene et al. (2006) | UC | Plasma | Propionylcarnitine | |
| Butyrylcarnitine | ||||
| Isovalerylcarnitine | ||||
| Octenoylcarnitine | ||||
| Decanoylcarnitine | ||||
| Myristoleylcarnitine | ||||
| Palmitoylcarnitine | ||||
| Oleylcarnitine | ||||
| Hydroxyoleylcarnitine | ||||
| Pearl et al. (2014) | UC | Tissue | Linoleic acid | |
| α-Linolenic acid | ||||
| Arachidonic acid | ||||
| Eicosapentaenoic acid | ||||
| Docosahexaenoic acid | ||||
| Docosapentaenoic acid | ||||
| Scoville et al. (2018) | CD | Serum | Not specifically mentioned | Long chain, polyunsaturated, branched chain, and monohydroxy fatty acids are the FA biomarker candidates. |
| Tefas et al. (2020) | CD | Serum | Linoleamide | |
| Palmitorylamide | ||||
| Palmitoleamide | ||||
| Branched fatty acid esters of hydroxy fatty acids | ||||
| Stearyl palmitoleate, Palmitoleyl stearate, Oleyl palmitate | ||||
| Masoodi et al. (2013) | UC | Tissue | 5-HETE | |
| 15-HETE | ||||
| Prostaglandin E2 | ||||
| Prostaglandin D2 | ||||
| Thromboxane B2 | ||||
| Lai et al. (2019) | CD | Serum | Docosahexaenoic acid | |
| Linolenic acid | ||||
| Arachidonic acid | ||||
| Pelargonic acid | ||||
| Propionylcarnitine | ||||
| Butyrylcarnitine | ||||
| Isovalerylcarnitine | ||||
| Heptanoylcarnitine |